eKapija | Search news

Number of results: 19

Begovic: Construction of Bio 4 Campus at End-Year, EUR 300 Million for First Phase

Tue 21.03.2023.

First Step Toward Construction of BIO4 Campus in Belgrade – Two Faculties and Five Science Institutes in One Place, Contest for Preliminary Design Soon

Sun 26.09.2021.

Papapostolou, Famous Regional Medical Leader, Start Operating in Serbia

Wed 16.12.2020.

Pfizer and BioNTech File Request for Registration of Vaccine Against Covid in Serbia

Thu 03.12.2020.

Import of Masks and Gloves Requires Filing of Request for Expert Opinion to Medicines and Medical Devices Agency of Serbia

Fri 27.03.2020.

Torlak Institute produces new seasonal flu vaccine after 15 years

Wed 11.12.2019.

Pavle Marjanovic, CEO of Actavis for Serbia and Montenegro – There are no “semi-quality” products in the market

Mon 25.06.2018.

Jugoremedija to be put up for sale in April for the third time – Creditors of Zrenjanin pharmaceutical plant announce complaint

Wed 28.03.2018.

Sale of Jugoremedija fails – No licenses, no buyers

Thu 12.10.2017.

Board of Creditors disputes advertised sale of Jugoremedija

Wed 20.09.2017.